Matinas BioPharma Inc.

AMEX: MTNB · Real-Time Price · USD
2.31
0.66 (40.00%)
At close: Aug 15, 2025, 3:59 PM
2.42
4.99%
After-hours: Aug 15, 2025, 07:58 PM EDT

Matinas BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-24.25M -22.94M -21M -23.28M
Depreciation & Amortization
972K 941K 898K 781.49K
Stock-Based Compensation
3.19M 4.95M 5.23M 4.29M
Other Working Capital
288K 1.77M -4.47M 945.13K
Other Non-Cash Items
4.41M 108K 504K 1.45M
Deferred Income Tax
-84K n/a n/a 2.21K
Change in Working Capital
-131K 1.67M -4.79M 1.53M
Operating Cash Flow
-15.88M -15.28M -19.16M -15.22M
Capital Expenditures
n/a -218K -892K -260.38K
Cash Acquisitions
n/a n/a -5.77M -17.03M
Purchase of Investments
-8.44M n/a -9.48M -23.19M
Sales Maturities Of Investments
17.64M 13.46M 15.25M 40.23M
Other Investing Acitivies
n/a n/a 5.77M 17.03M
Investing Cash Flow
9.21M 13.24M 4.88M 16.77M
Debt Repayment
-5K -7K -20K -30K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a -843.6M
Other Financial Acitivies
n/a n/a 99K 845.01M
Financial Cash Flow
9.17M -7K 79K 6.96M
Net Cash Flow
2.5M -2.04M -14.2M 8.51M
Free Cash Flow
-15.88M -15.5M -20.05M -15.48M